Lift BioSciences Announces Abstract Publications at the American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Foghorn Therapeutics Inc. (FHTX)
Company Research
Source: Yahoo! Finance
London, 24 May 2024 – LIfT BioSciences, (‘LIfT' or ‘the Company'), a rapidly emerging biotech company about to start clinical trials for its first-in-class allogeneic innate cell therapy, today announces the publication of two online abstracts at the annual American Society of Clinical Oncology, to be held from 31 May to 4 June 2024 in McCormick Place Convention Centre in Chicago, Illinois, US. Abstract Publications: Title : Immuno-Modulatory Alpha Neutrophils: The first-in-class neutrophil progenitor-based allogeneic immuno-cell therapy with cytotoxic and immunomodulatory functionality for the treatment of solid tumours Authors: Aoife McGinley, Samuel Florence, Martin James Woodward, Durva Patel, Andrew Willis, Alex Blyth, Alfonso Quintas-Cardama, Oxana Polyakova; LIfT Biosciences Ltd., London, United Kingdom; LIfT Biosciences, London, United Kingdom; Foghorn Therapeutics, Cambridge, MA Abstract number: e14523 Session type: Publication only Session title : Developmental
Show less
Read more
Impact Snapshot
Event Time:
FHTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FHTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FHTX alerts
High impacting Foghorn Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
FHTX
News
- Foghorn Therapeutics to Participate in Upcoming Investor Conferences in JuneGlobeNewswire
- Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline [Yahoo! Finance]Yahoo! Finance
- Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance PipelineGlobeNewswire
- Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]Yahoo! Finance
- Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded WarrantsGlobeNewswire
FHTX
Earnings
- 8/4/23 - Beat
FHTX
Sec Filings
- 6/24/24 - Form 4
- 6/10/24 - Form SC
- 6/3/24 - Form 8-K
- FHTX's page on the SEC website